Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

OBJECTIVE: To compare switching and discontinuation patterns of patients stable on originator infliximab (IFX) who switched to an IFX biosimilar (switchers) or remained on originator IFX (continuers) in the United States. METHODS: Symphony Health Solutions’ Patient Transactional Datasets (10/2012–03...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgerald, Timothy, Melsheimer, Richard, Lafeuille, Marie-Hélène, Lefebvre, Patrick, Morrison, Laura, Woodruff, Kimberly, Lin, Iris, Emond, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797299/
https://www.ncbi.nlm.nih.gov/pubmed/33442230
http://dx.doi.org/10.2147/BTT.S285610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797299/
https://www.ncbi.nlm.nih.gov/pubmed/33442230
http://dx.doi.org/10.2147/BTT.S285610

Ejemplares similares